Transmural Systems

Executive Summary

Transmural Systems is a privately held medical device company headquartered in Santa Rosa, California, specializing in innovative transcatheter devices for structural heart diseases. Founded in 2015, the company aims to address complex cardiac conditions through minimally invasive technologies, though specific product candidates and clinical development stages are not publicly disclosed. As a private entity with limited public information, Transmural Systems operates in the competitive cardiovascular device space, where differentiated technology and regulatory milestones are critical for growth. The company's success hinges on advancing its pipeline through preclinical or early clinical phases, securing funding, and establishing strategic partnerships. Given the lack of detailed pipeline data, the conviction score reflects moderate confidence in near-term value inflection.

Upcoming Catalysts (preview)

• Q2 2026Series A or B Financing Round70% success
• Q3 2026First Clinical Study Initiation or Data Readout50% success
• TBDFDA Breakthrough Device Designation40% success